Jupiter Asset Management Ltd. Buys New Holdings in Bruker Co. (NASDAQ:BRKR)

Jupiter Asset Management Ltd. acquired a new position in Bruker Co. (NASDAQ:BRKR) during the 3rd quarter, HoldingsChannel reports. The fund acquired 40,386 shares of the medical research company’s stock, valued at approximately $3,154,000.

A number of other institutional investors also recently added to or reduced their stakes in BRKR. Massachusetts Financial Services Co. MA boosted its position in Bruker by 3,381.9% in the 2nd quarter. Massachusetts Financial Services Co. MA now owns 1,038,827 shares of the medical research company’s stock worth $78,930,000 after purchasing an additional 1,008,992 shares in the last quarter. BlackRock Inc. raised its stake in shares of Bruker by 14.1% during the 2nd quarter. BlackRock Inc. now owns 6,513,896 shares of the medical research company’s stock worth $494,927,000 after buying an additional 805,046 shares during the period. Ceredex Value Advisors LLC raised its stake in shares of Bruker by 266.8% during the 3rd quarter. Ceredex Value Advisors LLC now owns 809,982 shares of the medical research company’s stock worth $63,259,000 after buying an additional 589,166 shares during the period. State Street Corp raised its stake in shares of Bruker by 35.9% during the 2nd quarter. State Street Corp now owns 2,050,445 shares of the medical research company’s stock worth $155,793,000 after buying an additional 541,579 shares during the period. Finally, Amundi acquired a new position in Bruker in the 2nd quarter valued at $40,590,000. Institutional investors and hedge funds own 68.38% of the company’s stock.

Several research firms recently commented on BRKR. Zacks Investment Research raised Bruker from a “hold” rating to a “buy” rating and set a $84.00 price objective for the company in a research note on Tuesday, September 28th. Wells Fargo & Company raised their target price on Bruker from $85.00 to $90.00 and gave the stock an “equal weight” rating in a research note on Tuesday, November 2nd. Three research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of $82.71.

In other Bruker news, Director Marc A. Kastner sold 10,000 shares of Bruker stock in a transaction that occurred on Wednesday, November 24th. The stock was sold at an average price of $76.86, for a total transaction of $768,600.00. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, VP Mark Munch sold 21,210 shares of Bruker stock in a transaction that occurred on Wednesday, December 15th. The stock was sold at an average price of $79.47, for a total value of $1,685,558.70. The disclosure for this sale can be found here. 26.80% of the stock is currently owned by company insiders.

Shares of BRKR opened at $70.72 on Friday. The stock has a 50-day simple moving average of $79.96 and a 200-day simple moving average of $81.10. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.36 and a current ratio of 2.16. The stock has a market capitalization of $10.72 billion, a PE ratio of 39.96, a PEG ratio of 1.51 and a beta of 1.24. Bruker Co. has a 1 year low of $54.46 and a 1 year high of $92.35.

Bruker (NASDAQ:BRKR) last announced its quarterly earnings data on Monday, November 1st. The medical research company reported $0.63 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.44 by $0.19. Bruker had a return on equity of 31.48% and a net margin of 11.44%. The business had revenue of $608.90 million during the quarter, compared to analysts’ expectations of $575.33 million. During the same quarter last year, the business posted $0.42 EPS. The business’s quarterly revenue was up 19.1% compared to the same quarter last year. Analysts predict that Bruker Co. will post 2.09 EPS for the current year.

The firm also recently announced a quarterly dividend, which was paid on Friday, December 17th. Stockholders of record on Wednesday, December 1st were given a dividend of $0.04 per share. This represents a $0.16 annualized dividend and a dividend yield of 0.23%. The ex-dividend date was Tuesday, November 30th. Bruker’s dividend payout ratio (DPR) is presently 9.04%.

About Bruker

Bruker Corp. engages in the development, manufacture, and distribution of scientific instruments, and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. It operates through the following segments: Bruker Scientific Instruments (BSI) Life Science, BSI Nano, and Bruker Energy and Supercon Technologies (BEST).

See Also: Municipal Bonds

Want to see what other hedge funds are holding BRKR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bruker Co. (NASDAQ:BRKR).

Institutional Ownership by Quarter for Bruker (NASDAQ:BRKR)

Receive News & Ratings for Bruker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker and related companies with MarketBeat.com's FREE daily email newsletter.